Lower costs to Medicare and Medicaid could lead to expanded coverage of GLP-1 medications by these programs, possibly through a pilot, as early as spring 2026
Kara Wada is a quadruple board-certified physician in allergy, immunology, and lifestyle medicine, and founder of the Immune Confident Institute
They digest slowly, preventing blood sugar spikes while keeping your digestive system regular
Over the years, she has focused her practice on non-surgical treatments and wellness-based care, including hormone health, metabolism, and injectable therapies
The GLP-1 receptor reduces appetite and slows gastric emptying
Most patients distinguish between the two: decreased hunger persists, while nausea fades